• Tidak ada hasil yang ditemukan

PAPILLARY CARCINOMA IN STRUMA OVARII: A CASE REPORT

N/A
N/A
Protected

Academic year: 2024

Membagikan "PAPILLARY CARCINOMA IN STRUMA OVARII: A CASE REPORT"

Copied!
1
0
0

Teks penuh

(1)

Pathology Macroscopic findings:

The specimen was a 37x35x27mm multiloculated ovarian mass with an 18x17x12mm solid area and cystic areas containing keratinous debris. There was no Rokitansky’s protuberance. The attached fallopian tube appeared normal. Peritoneal washings were not taken.

Microscopic findings:

Sections showed both cystic and solid areas. Pilosebaceous structures and adipose tissue were seen around the cyst wall.

More than 70% of the specimen was composed of thyroid tissue in solid and cystic patterns. There were papillae lined by follicular cells with optically clear, grooved, overlapping nuclei. The solid areas comprised compact follicles with the same nuclear features and also contained psammoma bodies.

Conclusion: Struma ovarii with papillary carcinoma in classical papillary form and as a follicular variant with prominent psammoma bodies.

PAPILLARY CARCINOMA IN STRUMA OVARII:

A CASE REPORT

Introduction

Struma ovarii is a form of teratoma composed predominantly of thyroid tissue, comprising 2.7% of all ovarian teratomas1. Malignancy may occur in 5-10% of struma ovarii2, thus accounting for 0.01% of all ovarian tumours. There is controversy as to the best management and follow-up of these cases. We describe a rare case of a 45 year-old woman with struma ovarii showing features of papillary carcinoma.

Discussion

Robboy et al3 found an overall 25-year survival rate of 84% in a review of 88 cases of thyroid-type tumours in struma ovarii. It is difficult to predict the behaviour of these lesions based on histology. Tumour removal appears to be curative for most small lesions that do not show extra-ovarian spread at the time of diagnosis. Risk factors for recurrence include larger size of struma, particularly if >12cm; presence of ascites or peritoneal adhesions at diagnosis; and defects in the ovarian serosa1,3. Papillary carcinomas recurred on average 4 years earlier than follicular lesions3. Mitotic rate does not aid prognostication1. Vascular invasion was uncommon in Robboy’s case series and therefore its prognostic value is unknown.

Notably, recurrence was not restricted to tumours that appeared histologically malignant. Recurrence was also observed after removal of histologically benign tumours such as follicular adenomas3. Due to the heterogeneous biological behaviour of neoplasms in struma ovarii, there is no standardised management pathway. Long-term routine clinical follow-up may be needed after initial surgery.

Clinical presentation

A 45 year-old parous woman presented with 12 months of pelvic pain and heavy irregular vaginal bleeding. She had no other symptoms and no clinical signs of thyroid hormone disturbance. There was no history of radiation exposure and no personal or family history of malignancy.

A pelvic ultrasound showed a small left-sided mass suggestive of a dermoid cyst. Laparoscopic left salpingo-oophorectomy was performed.

H&E (20x objective): Compact follicles with small papillae and overlapping optically clear nuclei

Ann Niap1, Swapna Kamal Sengupta2, Denys Fortune2, Ross Stillwell2 Dorevitch Pathology, Ballarat Base Hospital and Dorevitch Heidelberg, Victoria

1. Anatomical Pathology Registrar 2. Consultant Anatomical Pathologist

Outcome

The patient was subsequently investigated to exclude a primary thyroid neoplasm. Thyroid function tests were normal. An ultrasound showed multiple benign thyroid nodules up to 10mm each, one of which had minor non-specific uptake on FDG PET scan. Subsequent FNA cytology of this nodule was benign. It was decided not to perform an iodine-123 nuclear scan as her native thyroid would have decreased the test’s sensitivity. It was concluded that the patient had an incidental finding of papillary carcinoma in struma ovarii, independent of any thyroid pathology. She has a good prognosis in the absence of extra- ovarian spread.

H&E (2x objective): Cystic lesion with solid areas

References

1. Kurman et al: World Health Organization Classification of Tumours of Female Reproductive Organs. Lyon, IARC Press, 2014 2. Crum P, Nucci M, Lee K: Diagnostic Gynecologic and Obstetric Pathology. Elsevier Saunders, 2011

3. Robboy et al: Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol 28:405–422, Lippincott Williams & Wilkins, Baltimore, September 2009

H&E (20x objective): Compact follicles with overlapping optically clear nucleiand psammoma bodies H&E (2x objective): Compact follicles with psammoma bodies

Referensi

Dokumen terkait

by various names such as primary small cell carcinoma of skin, primary neuroendocrine carcinoma of skin, primary undifferentiated carcinoma of skin, anaplastic carcinoma of skin,

Article info: Received: June 05, 2022 Revised: July 02, 2022 Accepted: July 15, 2022 Keywords: Mature cystic teratoma; Malignant transformation; Squamous cell carcinoma; Ovary

55 Spring 2020, Volume 5, Issue 2 Journal Homepage: http://crcp.tums.ac.ir Metastatic Medullary Thyroid Carcinoma as a Presenting Feature of Multiple Endocrine Neoplasia 2B: A Case

Therefore, the expression of these chemoattractant receptors can Role of CXCR4 and MMP-9 Expressions with Regional Cervical Lymph Nodes Metastatic Status in Papillary Thyroid

Page 1 of 13 Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data Ji-Yeon Kim1,2#,

To the Editor It is an interesting observational study that has shown an increasing trend in the rates of papillary thyroid tumors in this region.It has clearly demonstrated an

Aggressive scalp and sternal lesion: A presentation of rare case of metastatic eccrine carcinoma ABSTRACT Introduction: Ductal Eccrine carcinoma DEC is a rare primary cutaneous

BN = benign follicular nodule, FA = follicular adenoma, FC = follicular carcinoma, FVPTC = follicular variant of papillary thyroid carcinoma, K-TIRADS = Korean Thyroid Imaging